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ABSTRACT 
Androgen deprivation therapy (ADT) is the standard treatment for advanced prostate cancer since 
prostate tumors initially are dependent on androgens for growth. However, most tumors will 
eventually relapse and grow in a highly aggressive and androgen-independent (AI) manner. AI 
prostate cancer is associated with poor prognosis and new treatment modalities are therefore 
urgently needed. Anti-angiogenic therapy could be one strategy to suppress tumor growth, but 
this requires an increased understanding about the regulation of angiogenesis in AI prostate 
cancer. The aim of this thesis was therefore to increase the knowledge about AI prostate cancer, 
with special focus on angiogenesis. First, an experimental model system that allows comparative 
studies of androgen-dependent (AD) and AI prostate cancer was established. An AD human 
prostate cancer cell line was cultured under selective pressure in androgen depleted medium, 
which resulted in an AI subline. Characterization of the newly established AI cell line revealed 
that transition into androgen-independency was associated with a more rapid tumor take, 
decreased PSA levels, increased microvessel density (MVD) and altered blood vessel 
morphology. To identify factors that could be of importance for the increased angiogenesis 
observed in AI tumors, a gene expression analysis was performed. The results demonstrated that 
transition into androgen-independency was accompanied with altered expression of a number of 
genes associated with angiogenesis, including ADAM metallopeptidase with thrombospondin 
type 1 motif, 1 (ADAMTS1). ADAMTS1 is a potent anti-angiogenic factor that was found to be 
significantly downregulated in AI cancer cells and its expression correlated negatively with MVD 
in the tumor xenografts. Furthermore, immunohistochemical studies of tumor tissue from prostate 
cancer patients demonstrated significantly lower levels of ADAMTS1 in cancer areas than in 
benign glands. In addition, low levels of ADAMTS1 were associated with metastatic disease and 
higher MVD in AI tumors. In order to further elucidate the role of ADAMTS1 in prostate cancer 
progression and tumor angiogenesis, the expression of ADAMTS1 was modified by transfection 
in the experimental model system. The results revealed that altered expression of ADAMTS1 
markedly affected the blood vessel morphology but not the number of blood vessels in the tumor 
xenografts. Modified expression of ADAMTS1 also affected the levels of the anti-angiogenic 
protein TSP1, whose expression was inversely related to ADAMTS1. Moreover, upregulation of 
ADAMTS1 resulted in a markedly delayed growth of AI tumors, while the opposite was 
observed in AD tumors. In summary, the results show that transition into androgen-independency 
is associated with increased angiogenesis and altogether the data from this thesis suggest that 
ADAMTS1 is an important factor in prostate cancer biology that is lost during disease 
progression and that is associated with decreased angiogenesis, tumor growth and metastasis in 
AI prostate cancer. 
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